These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15661528)

  • 1. Understanding transformation: progress and gaps.
    Boehm JS; Hahn WC
    Curr Opin Genet Dev; 2005 Feb; 15(1):13-7. PubMed ID: 15661528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of PP2A in viral and cellular transformation.
    Arroyo JD; Hahn WC
    Oncogene; 2005 Nov; 24(52):7746-55. PubMed ID: 16299534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.
    Karakosta A; Golias Ch; Charalabopoulos A; Peschos D; Batistatou A; Charalabopoulos K
    J Exp Clin Cancer Res; 2005 Dec; 24(4):505-14. PubMed ID: 16471312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein serine/threonine phosphatases: life, death, and sleeping.
    Gallego M; Virshup DM
    Curr Opin Cell Biol; 2005 Apr; 17(2):197-202. PubMed ID: 15780597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta and cancer.
    Bierie B; Moses HL
    Cytokine Growth Factor Rev; 2006; 17(1-2):29-40. PubMed ID: 16289860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple pathways regulated by the tumor suppressor PP2A in transformation.
    Westermarck J; Hahn WC
    Trends Mol Med; 2008 Apr; 14(4):152-60. PubMed ID: 18329957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular aspects of carcinogenesis in pancreatic cancer.
    Koliopanos A; Avgerinos C; Paraskeva C; Touloumis Z; Kelgiorgi D; Dervenis C
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):345-56. PubMed ID: 18693168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of cell growth and malignant transformation.
    Sulić S; Panić L; Dikić I; Volarević S
    Croat Med J; 2005 Aug; 46(4):622-38. PubMed ID: 16100767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics.
    Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ
    Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid receptor: roles in cancer.
    Aranda A; Martínez-Iglesias O; Ruiz-Llorente L; García-Carpizo V; Zambrano A
    Trends Endocrinol Metab; 2009 Sep; 20(7):318-24. PubMed ID: 19716314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional genetics and experimental models of human cancer.
    Zhao JJ; Roberts TM; Hahn WC
    Trends Mol Med; 2004 Jul; 10(7):344-50. PubMed ID: 15242683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
    Fodde R; Brabletz T
    Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells in solid tumors.
    Ailles LE; Weissman IL
    Curr Opin Biotechnol; 2007 Oct; 18(5):460-6. PubMed ID: 18023337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy.
    Lin CJ; Malina A; Pelletier J
    Cancer Res; 2009 Oct; 69(19):7491-4. PubMed ID: 19773439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation: an encouraging approach to anticancer therapy.
    Marchal JA; Rodríguez-Serrano F; Campos J; Madeddu R; Boulaiz H; Martínez-Amat A; Carrillo E; Caba O; Prados JC; Vélez C; Melguizo C; Montella A; Aránega A
    Ital J Anat Embryol; 2006; 111(1):45-64. PubMed ID: 16736717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell aging and cancer.
    Fuller J
    Sci Aging Knowledge Environ; 2006 May; 2006(9):pe12. PubMed ID: 16723637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
    Peebles KA; Lee JM; Mao JT; Hazra S; Reckamp KL; Krysan K; Dohadwala M; Heinrich EL; Walser TC; Cui X; Baratelli FE; Garon E; Sharma S; Dubinett SM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1405-21. PubMed ID: 17944566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.